| MeSH term | MeSH ID | Detail |
|---|---|---|
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Airway Remodeling | D056151 | 3 associated lipids |
| Acute Coronary Syndrome | D054058 | 11 associated lipids |
| Hypoalphalipoproteinemias | D052456 | 5 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Dyslipidemias | D050171 | 7 associated lipids |
| Cholecystitis, Acute | D041881 | 1 associated lipids |
| Pulmonary Disease, Chronic Obstructive | D029424 | 16 associated lipids |
| Metabolic Syndrome | D024821 | 44 associated lipids |
| Coronary Stenosis | D023921 | 6 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sullivan JC et al. | Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. | 2005 | Hypertension | pmid:15699443 |
| Chan CP et al. | Inhibition of cyclooxygenase activity, platelet aggregation and thromboxane B2 production by two environmental toxicants: m- and o-cresol. | 2005 | Toxicology | pmid:15664436 |
| Massicot F et al. | In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin. | 2005 | Basic Clin. Pharmacol. Toxicol. | pmid:15667592 |
| Lee GY et al. | Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. | 2005 | Thromb. Res. | pmid:15668191 |
| Gama de Abreu M et al. | Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. | 2005 | Anesthesiology | pmid:15731599 |
| Ye T et al. | [Insulin resistance and effects of intravenous acute saline load on renal production of prostaglandin I2 and thromboxane A2 in salt-sensitive hypertensive patients]. | 2005 | Di Yi Jun Yi Da Xue Xue Bao | pmid:15684012 |
| Arakawa K et al. | Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs. | 2005 | Dig. Dis. Sci. | pmid:15712633 |
| Pampolina C and McNicol A | Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. | 2005 | Thromb. Haemost. | pmid:15886812 |
| Ikonomidis I et al. | Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. | 2005 | Am. Heart J. | pmid:15894964 |
| Petrikova M et al. | Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets. | 2005 | Bratisl Lek Listy | pmid:15869009 |
| Komers R et al. | Renal cyclooxygenase-2 in obese Zucker (fatty) rats. | 2005 | Kidney Int. | pmid:15882258 |
| Chang P et al. | Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver. | 2005 | Dig. Dis. Sci. | pmid:15844712 |
| Bowen RS et al. | Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. | 2005 | Placenta | pmid:15850645 |
| Munsterhjelm E et al. | Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. | 2005 | Anesthesiology | pmid:16192763 |
| Hsiao G et al. | Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. | 2005 | J. Lab. Clin. Med. | pmid:16194683 |
| Xiaorong C et al. | Effects of medicinal cake-separated moxibustion on plasma 6-keto-PGF1alpha and TXB2 contents in the rabbit of hyperlipemia. | 2005 | J Tradit Chin Med | pmid:16136949 |
| Watanabe H et al. | Effects of salt loading on blood pressure in mice lacking the prostanoid receptor gene. | 2005 | Circ. J. | pmid:15635218 |
| Maruyama T et al. | Thromboxane-dependent portopulmonary hypertension. | 2005 | Am. J. Med. | pmid:15639216 |
| Sciulli MG et al. | Platelet activation in patients with colorectal cancer. | 2005 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:15626589 |
| Gonzalez-Conejero R et al. | Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? | 2005 | Stroke | pmid:15604423 |
| Zheng YN et al. | Effects of compounds in leaves of Salix matsudana on arachidonic acid metabolism. | 2005 | Yakugaku Zasshi | pmid:16327246 |
| Yugar-Toledo JC et al. | Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine. | 2005 | J Clin Hypertens (Greenwich) | pmid:16330894 |
| Falco A et al. | Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. | 2005 | Atherosclerosis | pmid:16285996 |
| Noguchi M et al. | Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites. | 2005 | Biol. Pharm. Bull. | pmid:16272692 |
| Ando K | [Synthesis of 2-, 4- and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans and their leukotriene B4 receptor antagonistic activity]. | 2005 | Yakugaku Zasshi | pmid:16272807 |
| de Sotomayor MA et al. | Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. | 2005 | Br. J. Pharmacol. | pmid:16231003 |
| Daza L et al. | Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients. | 2005 | Prostaglandins Other Lipid Mediat. | pmid:16303616 |
| Mason PJ et al. | Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. | 2005 | Am. J. Cardiol. | pmid:16275179 |
| Phillips J and Pearce B | Serum deprivation and re-addition: effects on cyclooxygenase inhibitor sensitivity in cultured glia. | 2005 | Inflammopharmacology | pmid:16280096 |
| Gambero A et al. | Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors. | 2005 | Inflammopharmacology | pmid:16280097 |
| Chang Y et al. | Mechanisms involved in the antiplatelet activity of ketamine in human platelets. | 2004 Nov-Dec | J. Biomed. Sci. | pmid:15591773 |
| Barrière G et al. | PHGPx overexpression induces an increase in COX-2 activity in colon carcinoma cells. | 2004 May-Jun | Anticancer Res. | pmid:15274299 |
| Ming HX et al. | [Influence of single leaf Asarum himalaicum on renal function of rabbits]. | 2004 | Zhong Xi Yi Jie He Xue Bao | pmid:15339444 |
| Dey A et al. | Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. | 2004 | Obes. Res. | pmid:15340111 |
| Sheu JR et al. | Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. | 2004 | Br. J. Pharmacol. | pmid:15289295 |
| Caprani A et al. | Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure. | 2004 | Bioelectromagnetics | pmid:15114641 |
| Di Minno G and Violi F | Aspirin resistance and diabetic angiopathy: back to the future. | 2004 | Thromb. Res. | pmid:15115664 |
| Torsney E et al. | Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. | 2004 | Circ. Res. | pmid:15117816 |
| Wang YY et al. | Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism. | 2004 | Acta Pharmacol. Sin. | pmid:15066215 |
| Park HS et al. | Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. | 2004 | J. Nutr. Biochem. | pmid:15068816 |
| Zhang C et al. | Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats. | 2004 | J. Cardiovasc. Pharmacol. | pmid:15071353 |
| Bruno A et al. | Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. | 2004 | Stroke | pmid:14963281 |
| Kwak SH et al. | Effects of propofol on endotoxin-induced acute lung injury in rabbit. | 2004 | J. Korean Med. Sci. | pmid:14966342 |
| Tanigawa T et al. | Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:12958020 |
| He W et al. | Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1alpha contents in rabbits with glucocorticoid-induced femoral head necrosis. | 2004 | J Tradit Chin Med | pmid:15510809 |
| Chiang N et al. | Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. | 2004 | Proc. Natl. Acad. Sci. U.S.A. | pmid:15471991 |
| Park WH et al. | Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. | 2004 | Life Sci. | pmid:15474558 |
| Chen BN et al. | [Characteristic changes of vascular tension factors in diabetic arterial occlusion of lower extremities]. | 2004 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:15495823 |
| Horani MH et al. | Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2. | 2004 | Metab. Clin. Exp. | pmid:14767868 |
| Peck OM et al. | Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. | 2004 | Shock | pmid:14770039 |